Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NVAX | Common Stock | Options Exercise | +3.1K | +442.86% | 3.8K | Jun 10, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NVAX | Restricted Stock Units | Options Exercise | $0 | -3.1K | -100% | $0.00* | 0 | Jun 10, 2023 | Common Stock | 3.1K | Direct | F1, F2 | |
transaction | NVAX | Stock Option (Right to Buy) | Award | $0 | +7.71K | $0.00 | 7.71K | Jun 12, 2023 | Common Stock | 7.71K | $7.78 | Direct | F3 | |
transaction | NVAX | Restricted Stock Units | Award | $0 | +6.67K | $0.00 | 6.67K | Jun 12, 2023 | Common Stock | 6.67K | Direct | F1, F4 |
Id | Content |
---|---|
F1 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. |
F2 | One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), vested on the first anniversary of the June 10, 2022 grant date subject to continued service on the Company's Board of Directors through the vesting date. |
F3 | One hundred percent (100%) of the shares subject to this option grant under the the Plan will vest one (1) year from the June 12, 2023 grant date (the "Grant Date") subject to continued service on the Company's Board of Directors through the vesting date. |
F4 | One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date. |